Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Jardiance" (16)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Metformin and Empagliflozin (A10BD20) 12 products
WHO-DDD
DrugBank.ca
L
IP
CI
PP
Jardiance Met 5 mg/500 mg
60 Tablet(s)
43.31
63.50
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
PP
Jardiance Met 5 mg/500 mg
180 Tablet(s)
129.91
157.70
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
PP
Jardiance Met 5 mg/850 mg
60 Tablet(s)
43.31
63.50
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
PP
Jardiance Met 5 mg/850 mg
180 Tablet(s)
129.91
157.70
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
PP
Jardiance Met 5 mg/1000 mg
60 Tablet(s)
43.31
63.50
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
PP
Jardiance Met 5 mg/1000 mg
180 Tablet(s)
129.91
157.70
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
PP
Jardiance Met 12.5 mg/500 mg
60
PR
PR
k.A.
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
IP
PP
Jardiance Met 12.5 mg/500 mg
180
PR
PR
k.A.
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
IP
PP
Jardiance Met 12.5 mg/850 mg
60
PR
PR
k.A.
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
IP
PP
Jardiance Met 12.5 mg/850 mg
180
PR
PR
k.A.
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
IP
PP
Jardiance Met 12.5
mg/1000 mg
60
PR
PR
k.A.
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
IP
PP
Jardiance Met 12.5
mg/1000 mg
180
PR
PR
k.A.
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
Empagliflozin (A10BK03) 4 products
WHO-DDD
DrugBank.ca
L
IP
CI
PP
Jardiance 10 mg
30 Tablet(s)
40.58
60.55
10 %
Coated tablets: Empagliflozinum 10 mg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
PP
Jardiance 10 mg
90 Tablet(s)
121.84
148.90
10 %
Coated tablets: Empagliflozinum 10 mg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
PP
Jardiance 25 mg
30
PR
PR
k.A.
Coated tablets: Empagliflozinum 25 mg
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
IP
CI
PP
Jardiance 25 mg
90
PR
PR
k.A.
Coated tablets: Empagliflozinum 25 mg
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
